Combining data sources to monitor the HIV epidemic in Canada

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue SUPPL. 1, 2003, Pages

  Archibald, Chris P ^a   Sutherland, Jason ^b   Geduld, Jennifer ^a   Sutherland, Donald ^a   Yan, Ping ^a  

^a HEALTH CANADA   (Canada)

^b CANADIAN INSTITUTE FOR HEALTH INFORMATION   (Canada)

Author keywords

AIDS; Behavioral surveillance; Canada; HIV; Injection drug users; Sentinel serosurveillance; Surveillance system

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANADA; DRUG ABUSE; EPIDEMIC; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SURVEY; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; METHODOLOGY; PREGNANCY TEST; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR;

EID: 0037326686     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200302011-00005     Document Type: Review

References (17)

1. CDC. Revision of the CDC surveillance case definition tor acquired immunodeficiency syndrome, MMWR 1987;36:1-15S.
2. Health Canada. HIV and AIDS in Canada: Surveillance Report to December 31, 2000. Ottawa: Division of HIV/AIDS Epidemiology and Surveillance, Bureau of HIV/AIDS, STD and TB, Centre for Infectious Disease Prevention and Control, Population and Public Health Branch, Health Canada, April 2001.
3. Health Canada. HIV/AIDS Epi Update. Prevalent HIV Infections in Canada: up to One-Third May Not Be Diagnosed, Bureau of HIV/AIDS, STD and TB, Centre for Infectious Disease Prevention and Control, Health Canada, May 2001.
4. Federal Centre for AIDS Working Group on Anonymous Unlinked HIV Seroprevalence. Guidelines on ethical and legal considerations in anonymous unlinked HIV seroprevalence research. CMAJ 1990;143:625-27 and 1992;146:1743-44.
5. Health Canada. Inventory of HIV Incidence and Prevalence Studies in Canada, Bureau of HIV/AIDS, STD and TB, Health Canada, May 2001.
6. Hankins C, Tran T, Desmarais D and the CACTUS Evaluation Team. Moving from surveillance to the measurement of program impact: Cactus-Montreal needle exchange program (NEP) [abstract 223]. Can J Infect Dis 1997;8:28A.
7. Baskerville B, Leonard L, Hotz SBH. Evaluation of the site: a pilot HIV prevention program for injection drug users (IDU), Ottawa Carleton Health Department. Final report to National Health Research and Development Program, March 1994.
8. Alary M, Hankins C, Parent R, et al. Faint light on the horizon? Trends in HIV prevalence, incidence, and needle borrowing among injection drug users participating in the SurvUDI study. Paper presented at the 10th Annual Canadian HIV Conference on HIV/AIDS Research, June 2-3, 2001, Toronto.
9. Tyndall M, Currie S, Pitchford M, et al. Incidence rates of HIV-1 infection and mortality in the VIDUS cohort: results at 30 months [abstract C311]. Can J Infect Dis 1999;10:45B.
10. Bruneau J, Lachance N, Lamothe F, et al. Changes in HIV seroconversion rates of IDUs attending needle exchange programs (NEP) in Montreal: the Saint-Luc cohort [abstract C312]. Can J Infect Dis 1999;10:45B.
11. Health Canada, HIV/AIDS Epi Update, HIV/AIDS among Aboriginal persons in Canada remains a pressing issue. Bureau of HIV/AIDS, STD and TB, Centre for Infectious Disease Prevention and Control, Health Canada, May 2001.
12. Houston SM, Archibald CP, Adrien A, et al. Development of a standardized set of questions to assess levels of HIV-risk behavior among the general population [abstract 256]. Can J Inf Dis 1997;8(Suppl B):37A.
13. Health Canada. HIV risk behaviors among Canadians: an inventory and synthesis. Ottawa: Division of HIV Epidemiology, Bureau of HIV/AIDS, STD and TB, Laboratory Centre for Disease Control, Health Protection Branch, Health Canada, November 1998.
14. Siushansian J, Houston SM, Archibald CP, et al. Sharing injection drug equipment: are Canadian injection drug users friendly to a fault? [abstract C367P] Can J Inf Dis 1999;10(Suppl B):60B.
15. Houston S, Archibald CP, Strike C, et al. Factors associated with HIV testing among Canadians: results of a population-based survey. Int J STD & AIDS 1998;9:341-46.
16. Geduld J, Archibald C. National trends of AIDS and HIV in Canada. CCDR 2000;26:193-201.
17. Archibald CP, Remis RS, Farley J, et al. Estimating HIV prevalence and incidence at the national level: combining direct and indirect methods with Monte-Carlo simulation [abstract 43475]. XII International Conference on AIDS. Geneva, 1998.